SCHEMBL4774784

SCHEMBL4774784

c1ccc(COc2nnc3ccccn23)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 7/20 0.49
ALDH1A1 P00352 3/20 0.49
HSD17B10 Q99714 3/20 0.46
PIM1 P11309 2/20 0.43
PIM2 Q9P1W9 2/20 0.43
GRM2 Q14416 1/20 0.41
ATP4A P20648 3/20 0.40
ATP4B P51164 3/20 0.40
RAB9A P51151 3/20 0.40
KMT2A Q03164 3/20 0.40
SMN1; SMN2 Q16637 3/20 0.40
HPGD P15428 2/20 0.40
NPC1 O15118 2/20 0.40
MEN1 O00255 2/20 0.40
CYP1A2 P05177 2/20 0.40
HDAC6 Q9UBN7 2/20 0.40
TDP1 Q9NUW8 1/20 0.40
GRM5 P41594 1/20 0.40
CYP3A4 P08684 1/20 0.40
CYP2D6 P10635 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20160390 0.74 KDM4E (0.50) KDM4EALDH1A1HSD17B10RAB9AKMT2A
SCHEMBL19292935 0.73 ALDH1A1 (0.54) KDM4EALDH1A1PIM1PIM2GRM2
SCHEMBL29564718 0.72 CTSV (0.51) KDM4EALDH1A1RAB9AKMT2ASMN1; SMN2
SCHEMBL4866580 0.71 KDM4E (0.79) KDM4EALDH1A1HSD17B10RAB9AKMT2A
SCHEMBL23895084 0.71 BRD4 (0.46) ALDH1A1RAB9AKMT2ASMN1; SMN2NPC1
SCHEMBL11536544 0.67 CDK8 (0.50) ATP4AATP4BCYP1A2HDAC6TDP1
SCHEMBL16382563 0.67 BRD4 (0.50) ALDH1A1ATP4AATP4BRAB9AKMT2A
SCHEMBL11490669 0.65 KDM4E (0.57) KDM4EALDH1A1HSD17B10RAB9AKMT2A
SCHEMBL4274920 0.65 LMNA (0.55) ALDH1A1RAB9ASMN1; SMN2CYP1A2HDAC6
SCHEMBL6219388 0.64 KDM4E (0.73) KDM4EALDH1A1HSD17B10PIM1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1971601-A2 N4-PHENYL-QUINAZOLINE-4 -AMINE DERIVATIVES AND RELATED COMPOUNDS AS ERBB TYPE I RECEPTOR TYROSINE KINASE INHIBITORS FOR THE TREATMENT OF HYPERPROLIFERATIVE DISEASES Array Biopharma Inc. (US) 2008-09-24 EP disclosed
WO-2007059257-A2 N4-PHENYL-QUINAZ0LINE-4 -AMINE DERIVATIVES AND RELATED COMPOUNDS AS ERBB TYPE I RECEPTOR TYROSINE KINASE INHIBITORS FOR THE TREATMENT OF HYPERPROLIFERATIVE DISEASES ARRAY BIOPHARMA INC. (US) 2007-05-24 WO disclosed